SynthesisAsian Pacific journal of cancer prevention : APJCP2025
Comparison of Clinical Outcomes of Thyroid Artery Embolization in the Treatment of Thyroid Nodules: A Meta-Analysis.
Synthesis in Asian Pacific journal of cancer prevention : APJCP, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveTo compare the clinical outcomes of thyroid artery embolization (TAE) in the treatment of thyroid nodules.
methodsA systematic review and meta-analysis were conducted following PRISMA guidelines. Relevant studies published between 1973 and 2023 were identified through PubMed, Cochrane Central, Web of Science, and Google Scholar. Eligible studies included randomized controlled trials and observational studies that evaluated TAE in patients with thyroid nodules. Data were extracted on hormonal levels (FT4, TSH), nodule volume, complications, quality of life, and surgical outcomes. Statistical analyses were performed using Review Manager 5.4.1 with fixed or random-effect models, and results were expressed with pooled mean differences or odds ratios with 95% confidence intervals (CIs).
resultsTen studies with a total of 347 patients were included. TAE significantly reduced nodule volume (mean difference: -51.95 mL, 95% CI: -78.58 to -25.33, p = 0.0001), increased TSH levels (mean difference: -0.63 µIU/mL, 95% CI: -1.10 to -0.16, p = 0.009), and reduced surgical blood loss and operative time. The odds ratio for minor versus major complications was 42.60 (95% CI: 17.51 to 103.64, p < 0.00001), indicating a favorable safety profile. Quality of life showed a trend toward improvement, although not statistically significant (OR: 27.72, 95% CI: 0.47 to 1648.47, p = 0.11).
conclusionTAE appears to be a safe and potentially effective procedure for reducing thyroid nodule volume and improving surgical outcomes. However, conclusions should be interpreted cautiously due to high heterogeneity and the observational nature of the included studies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.